Cargando…

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials

This meta-analysis combines the results of two identical stroke studies (CARS-1 and CARS-2) assessing efficacy of Cerebrolysin on motor recovery during early rehabilitation. Cerebrolysin is a parenterally administered neuropeptide preparation approved for the treatment of stroke. Both studies had a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guekht, Alla, Vester, Johannes, Heiss, Wolf-Dieter, Gusev, Eugene, Hoemberg, Volker, Rahlfs, Volker W., Bajenaru, Ovidiu, Popescu, Bogdan O., Doppler, Edith, Winter, Stefan, Moessler, Herbert, Muresanu, Dafin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605586/ https://www.ncbi.nlm.nih.gov/pubmed/28707130 http://dx.doi.org/10.1007/s10072-017-3037-z

Ejemplares similares

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
por: Muresanu, Dafin F., et al.
Publicado: (2016)

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials
por: Bornstein, Natan M., et al.
Publicado: (2017)

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010)

Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery
por: Jianu, DC, et al.
Publicado: (2010)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022)

Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial
por: Gharagozli, K, et al.
Publicado: (2017)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014)

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
por: Alvarez, X. Anton, et al.
Publicado: (2016)

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
por: Mureșanu, Ioana Anamaria, et al.
Publicado: (2022)

Effects of cerebrolysin on nerve growth factor system in the aging rat brain
por: Stepanichev, Mikhail, et al.
Publicado: (2017)

Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
por: Formichi, Patrizia, et al.
Publicado: (2012)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
por: Verisezan Rosu, Olivia, et al.
Publicado: (2023)

C-REGS 2 - Design and methodology of a high-quality comparative effectiveness observational trial
por: Vester, Johannes, et al.
Publicado: (2021)

Celebrating the legacy of Prof. Ovidiu Alexandru Bajenaru
por: Muresanu, Dafin, et al.
Publicado: (2022)

Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management
por: Sharma, Hari S, et al.
Publicado: (2011)

Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009)

Academia steps up to strengthen health policymaking in Romania: a roadmap for tackling difficulties encountered by Ministry of Health specialty commissions
por: Muresanu, Dafin, et al.
Publicado: (2021)

Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study
por: Băjenaru, Ovidiu, et al.
Publicado: (2014)

Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles
por: Sharma, Hari Shanker, et al.
Publicado: (2023)

The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury
por: Birle, Codruta, et al.
Publicado: (2020)

Neurobiology of Vascular Dementia
por: Enciu, Ana-Maria, et al.
Publicado: (2011)

Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
por: Morega, Shandiz, et al.
Publicado: (2021)

Cerebrolysin Use in Patients with Liver Damage—A Translational Study
por: Morega, Shandiz, et al.
Publicado: (2022)

Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression
por: Livinț Popa, Livia, et al.
Publicado: (2022)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
por: Rockenstein, Edward, et al.
Publicado: (2015)

Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department
por: Davidescu, Eugenia Irene, et al.
Publicado: (2021)

CACNA1B gene variants in adult-onset isolated focal dystonia
por: Cocoș, Relu, et al.
Publicado: (2020)

Evaluation of post-traumatic stress disorder (PTSD) and related comorbidities in clinical studies
por: Mureșanu, Ioana Anamaria, et al.
Publicado: (2022)

Neuroregeneration in neurodegenerative disorders
por: Enciu, Ana M, et al.
Publicado: (2011)

In memoriam: Professor Ovidiu Alexandru Bajenaru (1957-2020)
por: Muresanu, Dafin
Publicado: (2020)

2021: New horizons in neurorehabilitation
por: Muresanu, Dafin
Publicado: (2021)

Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
por: Jarosz, Konrad, et al.
Publicado: (2023)

Non-Motor Manifestations in Idiopathic Dystonia with Focal Onset – A Pilot Study
por: Bajenaru, Ovidiu-Lucian, et al.
Publicado: (2020)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

Brain recovery – towards an unified theory
por: Mureşanu, Dafin F
Publicado: (2010)

Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
por: Georgy, Gehan S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rogvamphkuo2mgolph8cute3de